A randomised clinical trial (RCT) of the effect of Neuro-Emotional Technique (NET) on the clinical manifestations of primary overt hypothyroidism

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12607000040460

Enrollment

102

Registered

2007-01-12

Start date

2006-12-10

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project is a comparative study investigating the effects of Neuro-Emotional Technique (NET) treatment on Hypothyroidism. Hypothyroidism is defined as any condition that results in a decrease in the amount of circulating thyroid hormones in the body. NET is a therapeutic procedure developed by Chiropractors as an adjunct to standard Chiropractic techniques. The development and structure of this technique ties in with the biopsychosocial model of health care, which represents a holistic approach to patient management. General aims: -To determine the effect of Neuro-Emotional Technique (NET) in the treatment and management of primary hypothyroidism. Specific Aims: - To determine the emotional/ psychological/ social/ hormonal profile of a group of primary overt hypothyroid participants. - To determine if the emotional/psychological/ social/hormonal profile of a group of primary overt hypothyroid participants changes with NET treatment. - To determine if primary overt hypothyroidism can be affected by NET treatment in the short term (2 months) and the medium term (6 months) Interpretation of Results and Discussion Accumulated data will be statistically analysed using T-tests, longitudinal analysis with an alpha value of 0.05

Interventions

Neuro-Emotional Technique (NET) Neuro-Emotional Technique is a technique used by chiropractors which is similar to Cognitive behavioural therapy (CBT). Participants in the treatment group will receive 10 NET treatments over a period of 6 weeks. The treatments will last for approximately 5-20 mins in duration.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Hypothyroid sufferers.

Exclusion criteria

Iatrogenic hypothyroidism, < 18 years, significant co-morbidities, Deaf/mute, Non-English speaking, Serious illness/mental illness, Pregnant, Individuals recently diagnosed (within the last 6 months) with hypothyroidism, medications that are known to influence thyroid function other than standard meds for hypothyroidism.

Outcome results